Trial intelligence / Profile preview

COBRA trial of very short-course versus standard-course antibiotics after adequate ERCP drainage for acute cholangitis

NL-OMON56128Completed

Sponsor
Amsterdam University Medical Center
Start
Mar 2023
Countries
1
01

Overview

Randomised, open-label trial in acute cholangitis (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Clinical cure. Started Mar 2023; status: completed.

02

Conditions

acute cholangitis

Beyond the preview

Go deeper on NL-OMON56128.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON56128.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call